Account
News
04.01.2023
PMA Insights: Week 1

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
08.12.2022
EU HTA – looking back on 2022

Our market access experts cover the changes to the joint EU HTA process that occurred in 2022 and wh...

Read more
Webinar
08.12.2022
Are you ready for the new EU HTA in 2025?

Webinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint ...

Read more
30.11.2022
Reflecting on the Pricing & Market Access tren...

Our experts reflect on the trends that shaped the European pricing and market access landscape in 20...

Read more
Publications
07.11.2022
ISPOR 2022 Plenary Session 1 - HTA and Regulation

Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...

Read more
News
02.11.2022
PMA Insights: Week 44

We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...

Read more
Insider Insights
01.11.2022
A winter of discontent? European pharmaceutical so...

EUCOPE and EFPIA have issued a joint statement expressing concerns regarding the implementation of t...

Read more
Articles
22.06.2022
EU Joint HTA: How should manufacturers adapt to th...

EUnetHTA and the EU Joint HTA Process EUnetHTA was established in 2006 to facilitate information sha...

Read more
Articles
21.06.2022
Seeking early advice from the EMA and multiple HTA...

Introduction Achieving access to patients for innovative treatments is becoming a significant challe...

Read more
Articles
07.06.2022
EU Joint HTA: What’s going on and what does it m...

EUnetHTA and the EU Joint HTA Process Originally set up in 2006, EUnetHTA was established to facilit...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.